3 New Members on the CATALIS’ Board of Directors
CATALIS is pleased to announce the appointments of Alain Couture, Natalie Verreault and Patrick Montpetit to the Board of Directors as board members.
The Board of Directors Welcomes Alain Couture
“It is with great pleasure that I join the CATALIS Board of Directors. I am eager to contribute to the organization’s initiatives and collaborate to support the mission of advancing and accelerating clinical research. My goal is to promote the integration of health innovations and attract more research investments to Quebec, all for the benefit of patients.”
– Alain Couture, Senior Head, Government Affairs and Strategic Partnerships for Quebec, GSK
Alain Couture holds a Bachelor’s degree in Business Administration from Laval University. He is currently Senior Head of Government Affairs and Strategic Partnerships for Quebec at GSK. Over his 30-year tenure at GSK, Mr. Couture has developed a deep expertise in government affairs management, market access, sales, and the development of strategic relationships with external clients and key stakeholders in the healthcare sector.
Alain has been a member of the steering committee of Innovative Medicines Canada (IMC) for over 10 years. He represents GSK in organizations such as Montreal InVivo and Québec International, as well as other major life sciences bodies.
The Board of Directors Welcomes Natalie Verreault
“It is a privilege to join CATALIS Quebec’s Board of Directors, a leading organization dedicated to accelerating clinical research. Placing patients’ needs at the heart of priorities is a crucial responsibility. I am eager to collaborate with this board of leaders to support the development of initiatives that concretely improve access to innovative treatments, thereby meeting the expectations of Quebec patients. Together, we are working to transform their care experience, advance science, and bring hope.”
– Natalie Verreault, Senior Manager, Health System and Government Affairs, Roche Canada
Natalie Verreault, Senior Manager of Health System and Government Affairs at Roche Canada, has over 25 years of experience in the pharmaceutical industry.
A graduate of Laval University’s business administration program, Natalie is also a Certified Market Access Professional (CAHR). She has developed deep expertise in management, sales, strategic partnership development, and government affairs. She is actively involved in Innovative Medicines Canada (IMC) and several sectorial working groups.
The Board of Directors Welcomes Patrick Montpetit
“I am honored to join the Board of Directors of CATALIS Quebec and to support its mission. Optimizing the clinical research environment by putting patients at the center of its priorities positions Quebec as a major player in the international biotechnology industry. I am truly moved to finally be able to contribute my expertise of the last 30 years to the benefit of our patients.”
– Patrick Montpetit CPA, Executive Chairman, Biodextris
As a partner and Chief Financial Officer of private and public companies for 28 years, Patrick Montpetit has a proven track record of leadership focused on creating value and developing growth strategies to maximize shareholder value from an exit perspective.
As a Canadian CPA, he brings extensive international financial management experience, having worked in North America, Europe, LATAM, and Asia.
The members of the Board of Directors would like to express their gratitude to the outgoing members, Jefferson Tea and Patrice Roy, for their invaluable contribution. Having served on the Board since 2019 and 2023 respectively, both have demonstrated an outstanding commitment to the mission of CATALIS.
